Existing contradictions on TRPC6 channel function in AD and ischemia indicate that these NDDs might be heterogenic, meaning that in one group of patients, the disease leads to hypofunction of the TRPC6 channel; however, there is another group (most likely smaller than the first one) where TRPC6 is hyperactivated. Here, TRPC6 is linked to ischemia.